A novel role of fibroblast growth factor-2 and pentosan polysulfate in the pathogenesis of intestinal bleeding in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 2, 2007, Pages

  Jerebtsova, Marina ^a,c   Wong, Edward ^b,c   Przygodzki, Ronald ^b,c   Tang, Pingtao ^a   Ray, Patricio E ^a,b,c  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Abdominal hemorrhages; Angiogenesis; Coagulation; Heparin binding receptors; Heparinoids

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; FIBROBLAST GROWTH FACTOR 2; PENTOSAN POLYSULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INTESTINAL BLEEDING; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION; BLOOD VESSELS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GASTROINTESTINAL HEMORRHAGE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTESTINAL DISEASES; INTESTINES; MALE; MICE; MICE, INBRED C57BL; PENTOSAN SULFURIC POLYESTER; PROTEIN BINDING; TIME FACTORS;

EID: 33846951184     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00969.2006     Document Type: Article

References (34)

1. Aviezer D, Iozzo RV, Noonan DM, Yayon AV. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell 79: 1005-1013, 1994.
2. Barabino GA, Liu XD, Ewenstein BM, Kaul DK. Anion polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior. Blood 93: 1422-1429, 1999.
3. Day R, Forbes A. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 354: 62-65, 1999.
4. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371: 674-680, 1994.
5. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
6. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MPM, Presta M. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162: 1913-1926, 2003.
7. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factors. Endocr Rev 8: 95-114, 1987.
8. Gupta AR, Dejneka NS, D'Amato RJ, Yang Z, Syed N, Maguire AM, Bennet J. Strain-dependent anterior segment neovascularization following intravitreal gene transfer of basic fibroblast growth factor (bFGF). J Gene Med 3: 252-259, 2001.
9. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612, 1998.
10. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis area. J Clin Invest 108: 349-355, 2001.
11. Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231, 1991.
12. Kozarsky K, Grossman M, Wilson JM. Adenovirus-mediated correction of the genetic defects in hepatocytes from patients with familial hyper-cholesterolemia. Somat Cell Mol Genet 19: 449-458, 1993.
13. Ku PT, D'Amore PA. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biochem 58: 328-343, 1995.
14. Levine A, Kenet G, Bruck R, Avni Y, Avinoach I, Aeed H, Matas Z, David M, Yayon A. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats. Pediatr Res 51: 635-640, 2002.
15. Li Y, Wang HY, Cho CH. Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats. J Pharmacol Exp Ther 290: 789-796, 1999.
16. Marshall JL, Wellstein A, Rae J, DeLap RJ, Phipps K, Hanfelt J, Yunmbam MK, Sun JX, Duchin KL, Hawkins MJ. Phase I trial of orally administered pentosan polysulphate in patients with advanced cancer. Clin Cancer Res 3: 2347-2354, 1997.
17. McDonnell K, Bowden ET, Cabal-Manzano R, Hoxter B, Riegel AT, Wellstein A. Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Lab Invest 85: 747-755, 2005.
18. McKeehan WL, Wu X, Kan M. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J Biol Chem 274: 21511-21514, 1999.
19. Nugent MA, Nugent HM, Iozzo RV, Sanchack K, Edelman ER. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci USA 97: 6722-6727, 2000.
20. 3H-pulphate to the urinary tract in rats. Pharmacol Toxicol 61: 162-166, 1987.
21. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, and Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297, 2001.
22. Pluda JM, Shay LE, Foli A, Tannenbaum S, Cohen PJ, Goldspie BR, Debra A, Copper MR, Broder S, Yarchoan R. Administration of pentosan polysulphate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst 85: 1585-1592, 1993.
23. Ray PE, Acheson R, Chitrakar R, Cnaan A, Gibbs K, Hirschman GH, Cristen E, Trachtman H, and Investigators of the Hemolytic Uremic Syndrome-Synsorb PK Multicenter Clinical Trial. Basic fibroblast growth factor in children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol 13: 699-707, 2002.
24. Ray PE, Liu XH, Xu L, Rakusan T. Accumulation of bFGF in children with HIV-1 associated Hemolytic Uremic Syndrome (HIV-HUS). Pediatr Nephrol 13: 586-593, 1999.
25. Ribatti D, Gualandris A, Belleri M, Massardi L, Nico B, Rusanti M, Dell Era P, Vacca A, Roncali L, Presta M. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2. J Pathol 189: 590-599, 1999.
26. Scully MF, Weerasinghe KM, Ellis V, Djazaeri B, Kakkar VV. Anticoagulant and antiheparin activities of a pentosan polysulphate. Thromb Res 31: 87-89, 1983.
27. Sivak-Kroizman T, Lemmon MA, Dickic I, Ladbury JE, Pinchasi D, Huan J, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79: 1015-1024, 1994.
28. Soria C, Soria J, Ryckewaert JJ, Holmer E, Caen JP. Anticoagulant activities of a pentosan polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin. Thromb Res 19: 455-463, 1980.
29. Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, Sturzul M, Butto S, Cafaro A, Monini P, Ensoli B. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix- metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 12: 2934-2946, 2001.
30. Wellstein A, Zugmaier G, Califano JA 3rd, Kern F, Paik S, Lippman ME. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulphate. J Natl Cancer Inst 83: 716-720, 1991.
31. Whalen GF, Shing Y, Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1: 157-164, 1989.
32. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell Surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptors. Cell 64: 841-848, 1991.
33. Ye X, Jerebtsova M, Ray PE. Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney. Hum Gene Ther 11: 621-627, 2000.
34. Zugmaier G, Lippman ME, Wellstein A. Inhibition by pentosan polysulphate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J Natl Cancer Inst 84: 1716-1724, 1992.